Literature DB >> 7106417

Iodination with Iodo-gen and radioimmunoassay of cholecystokinin (CCK) in acidified plasma, CCK release, and molecular CCK components in man.

P G Burhol, T G Jenssen, I Lygren, T B Schulz, R Jorde, H L Waldum.   

Abstract

The preparation of a stable fully immunoreactive 125I-labeled CCK39 using a modified Iodo-gen method with high specific radioactivity; the production of an avid and specific cholecystokinin (CCK) antiserum, and a sensitive, precise and specific radioimmunoassay method allowing measurements of fasting plasma CCK in the low picomole per liter range together with the significant rises in plasma CCK following a test meal and duodenal infusion of fat are described. Apparent immunoreactive fasting plasma CCK was eluted from a Sephadex G-50 Fine column in one peak probably representing plasma CCK bound to plasma proteins and nonspecific plasma effects. Apparent immunoreactive postprandial plasma CCK was eluted from a Sephadex G-50 Fine column in four peaks. The first peak probably represents plasma CCK bound to plasma proteins and nonspecific plasma effects; the second peak probably represents component I with a molecular weight between some 5,000 and 30,000; the third peak probably represents component II or CCK33, and the fourth peak probably represents component IV or CCK8.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7106417     DOI: 10.1159/000198723

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  2 in total

1.  Plasma cholecystokinin concentrations in patients with pancreatic insufficiency measured by sequence-specific radioimmunoassays.

Authors:  J B Jansen; W P Hopman; C B Lamers
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

2.  The neuropeptide head activator loses its biological acitivity by dimerization.

Authors:  H Bodenmüller; E Schilling; B Zachmann; H C Schaller
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.